The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 407.00
Bid: 402.50
Ask: 414.00
Change: 1.00 (0.25%)
Spread: 11.50 (2.857%)
Open: 408.00
High: 409.50
Low: 404.00
Prev. Close: 406.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AT1s Contingent Convertible securities

17 Nov 2023 07:00

RNS Number : 7589T
Banco Santander S.A.
16 November 2023
 

Banco Santander, S.A. ("Banco Santander" or the "Bank"), in compliance with the Securities Market legislation, hereby announces the following:

 

OTHER RELEVANT INFORMATION

Banco Santander announces that it has completed the placement of two series of preferred securities contingently convertible into newly issued ordinary shares of the Bank, excluding the pre-emptive subscription rights of its shareholders, for a total nominal amount of two billion five hundred million U.S. dollars ($ 2,500,000,000) (the "Issue" and the "CoCos"). The total nominal amount of the Issue is divided as follows between each of the two series:

(i) Series 13: with a nominal amount of one billion one hundred and fifty million U.S. dollars ($ 1,150,000,000).(ii) Series 14: with a nominal amount of one billion three hundred and fifty million U.S. dollars ($ 1,350,000,000).

The placement of the Issue has been carried out through an accelerated book-building targeted at professional investors and eligible counterparties only.

The CoCos are issued at par and its remuneration, the payment of which is subject to certain conditions and to the discretion of the Bank, has been set as follows for each of the two series:

(i) Series 13: at 9.625% on an annual basis for the first 5 years and 6 months, which will be reviewed every 5 years thereafter, in accordance with the terms and conditions of the CoCos, by applying a margin of 530.60 basis points to the rate resulting from the applicable 5-year UST.(ii) Series 14: at 9.625% on an annual basis for the first 10 years, which will be reviewed every 5 years thereafter, in accordance with the terms and conditions of the CoCos, by applying a margin of 529.80 basis points to the rate resulting from the applicable 5-year UST.

Once issued, the CoCos will be eligible as additional tier 1 capital of Banco Santander in accordance with Regulation (EU) No. 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms ("CRR"). The CoCos are perpetual, but they may be called under certain circumstances and would be converted into newly issued ordinary shares of Banco Santander if the common equity tier 1 (CET1) ratio of the Bank or its consolidated group, calculated in accordance with CRR, were to fall below 5.125%. As of 30 September 2023, the fully loaded consolidated CET1 ratio of the Bank was 12.3%.

The Bank will request the admission of the CoCos to trading on the New York Stock Exchange.

The Bank also announces that, as of today, the report of the directors of the Bank concerning the basis and rules for the conversion of the CoCos and the exclusion of pre?emptive subscription rights, issued in accordance with articles 414.2, 417.2 and 510 of the Spanish Companies Act (Ley de Sociedades de Capital), will be available on the Bank's website (www.santander.com). The aforementioned report will also be provided to the shareholders at the first general shareholders' meeting to be held after the Issue.

 

Boadilla del Monte (Madrid), 16 November 2023

IMPORTANT INFORMATION

This other relevant information notice does not constitute an offer to sell, or the solicitation of an offer to buy these securities, nor shall there be any sale of such securities in any state of the United States or in any other jurisdiction in which such offer, solicitation or sale would not be permitted before registration or qualification under the securities laws of such state or jurisdiction. This document may not be distributed, directly or indirectly, in any jurisdiction in which said distribution is contrary to applicable laws.

No action has been made or will be taken that would permit a public offering of any securities described herein in any jurisdiction in which action for that purpose is required. No offers, sales, resales or delivery of any securities described herein or distribution of any offering material relating to any such securities may be made in or from any jurisdiction except in circumstances which will result in compliance with any applicable laws and regulations and which will not impose any obligation on the Bank or the underwriters of the Issue or any of their respective affiliates.

In connection with the Issue of the CoCos, the Bank has filed a registration statement (including a prospectus), and a prospectus supplement with the US Securities and Exchange Commission (the "SEC"). Before you invest, you should read the prospectus and prospectus supplement included in that registration statement and the other documents the Bank has filed with the SEC for more complete information about the Bank and the offer of the CoCos. You may obtain these documents for free by visiting the SEC's web site at www.sec.gov.

This notice is an announcement and not a prospectus, and investors should not subscribe for or purchase any securities referred to herein except on the basis of the information included in the prospectus and the prospectus supplement and the other documents filed by the Bank with the SEC that are incorporated by reference in the registration statement.

This notice does not constitute an offer document or an offer of transferable securities to the public in the United Kingdom in accordance with the Financial Services and Markets Act 2000 ("FSMA") and should not be considered as a recommendation that any person should subscribe for or purchase any of the securities described herein. These securities will not be offered or sold to any person in the United Kingdom except in circumstances which have not resulted and will not result in an offer to the public in the United Kingdom in contravention of the FSMA.

This notice does not constitute an offer to the public in Italy of financial products, as defined under legislative decree no. 58 of 24 February 1998, as amended (the "Financial Services Act"). The offering of the preferred securities has not been registered with the Commissione Nazionale per le Società e la Borsa ("CONSOB") pursuant to Italian securities legislation and, accordingly, the securities described herein may not be offered, sold or delivered, nor any copies of the prospectus, the prospectus supplement or of any other document relating to the preferred securities be distributed in Italy, except: (a) to qualified investors (investitori qualificati), as defined pursuant to Article 2 of the Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the "Prospectus Regulation") and any other applicable regulation of the Financial Services Act and the Italian CONSOB Regulation ("CONSOB Regulation"); or (b) in any other circumstances which are exempted from the rules on public offerings pursuant to Article 1 of the Prospectus Regulation, Article 100 of the Financial Services Act, Article 34ter of the CONSOB Regulation No. 11971 of 14 May 1999, as amended from time to time, and the applicable Italian laws.

The offer, sale or distribution of CoCos, as well as any subsequent resale, cannot be carried out in Spain unless it complies with all legal and regulatory requirements under Spanish securities laws or in circumstances that do not require the registration of a prospectus in Spain.

This notice is for information purposes only and does not constitute and shall not, in any circumstances, constitute a public offering or an invitation to the public in connection with any offer within the meaning of the Prospectus Regulation.

As set out in the CoCos' prospectus and prospectus supplement, there are further restrictions to offer, sale or distribute in different jurisdictions, including Canada, Hong Kong, Japan, the People's Republic of China, Republic of Korea, Taiwan, Singapore, Switzerland and Australia.

Restrictions on marketing and sale and resale to retail investors

The CoCos are not intended to be offered, sold or otherwise made available and should not be offered, sold or otherwise made available to retail clients (as defined in Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on Markets in Financial Instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II), as amended or replaced from time to time, and Regulation (EU) 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act of 2018 (EUWA)). Prospective investors are referred to the section headed "Important Information" of the prospectus supplement for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODGPGRAGUPWPGQ
Date   Source Headline
15th Sep 20211:08 pmRNSForm 8.3 - Ultra Electronics Holdings plc
3rd Sep 20212:56 pmRNSForm 8.3 - NortonLifeLock Inc.
3rd Sep 20212:40 pmRNSForm 8.3 - Avast Plc
3rd Sep 20212:20 pmRNSForm 8.3 - Meggitt Plc
2nd Sep 20211:04 pmRNSOptional early redemption of Preferred Securities
24th Aug 20217:00 amRNSAgreement between SHUSA & SCUSA Holdings
3rd Aug 202112:13 pmRNSDirector/PDMR Shareholding
30th Jul 20215:13 pmRNSStress Test Results
30th Jul 202110:35 amRNSOptional early redemption ISIN XS1107291541
28th Jul 20217:00 amRNS1H2021 results report & analyst presentation
28th Jul 20217:00 amRNSFirst half 2021 results press release
27th Jul 20213:02 pmRNSNotice of First Half 2021 Results
15th Jul 20215:07 pmRNSAcquisition of Amherst Pierpont Presentation
15th Jul 20215:05 pmRNSSantander to acquire Amherst Pierpont
10th Jun 202112:11 pmRNSDirector/PDMR Shareholding
9th Jun 20217:00 amRNSSantander Mexico tender offer supplementary info
25th May 20217:00 amRNSSantander Mexico tender offer supplementary info
21st May 20218:43 amRNSForm 8.3 - RSA Insurance Group plc
7th May 20217:00 amRNSIssue of Preferred Tier 1 Securities CoCos
30th Apr 202112:03 pmRNSDirector/PDMR Shareholding
30th Apr 20218:04 amRNS2020 Banco Santander Annual Report
28th Apr 20217:00 amRNSFirst Quarter 2021 Earnings Presentation
28th Apr 20217:00 amRNSFirst Quarter 2021 Financial Report
28th Apr 20217:00 amRNSFirst Quarter 2021 press release
27th Apr 20213:06 pmRNSNotice of Results for the 1st Quarter 2021
20th Apr 202111:04 amRNSForm 8.3 - RSA Insurance Group
9th Apr 202112:53 pmRNSChange in the Group’s reportable segments
6th Apr 20211:51 pmRNSForm 8.3 - RSA Insurance Group Plc
26th Mar 20211:53 pmRNSAGM Resolutions
26th Mar 20217:00 amRNSSantander Mexico Tender Offer Presentation
26th Mar 20217:00 amRNSInformation on Santander Mexico, dividends, Board
26th Mar 20217:00 amRNSAnalysts call on Santander Mexico tender offer
26th Mar 20217:00 amRNSInformation on payment of dividends
19th Mar 202111:19 amRNSAdditional notice to the call to the AGM
11th Mar 20215:08 pmRNSDirector/PDMR Shareholding
11th Mar 20215:07 pmRNSDirector/PDMR Shareholding
26th Feb 202112:21 pmRNSDirector/PDMR Shareholding
26th Feb 202112:21 pmRNSDirector/PDMR Shareholding
23rd Feb 20214:13 pmRNSNotice of AGM
23rd Feb 20214:00 pmRNSAnnual Financial Report
18th Feb 20215:32 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:30 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:29 pmRNSDirector/PDMR Shareholding
18th Feb 20215:28 pmRNSDirector/PDMR Shareholding
18th Feb 20215:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.